|
|
|
|
|
|
|
|
|
08.09.26 - 14:36
|
Octave Specialty Group Appoints Philip Stefano Head of Investor Relations (Business Wire)
|
|
|
NEW YORK--(BUSINESS WIRE)--Octave Specialty Group, Inc. (“Octave”) (NYSE: OSG), a global specialty insurance firm, today announced that Philip Stefano has joined the company as Managing Director, Head of Investor Relations.
Stefano joins from Essent Group, where he was Vice President of Investor Relations and Corporate Development for the last five years. Prior to that, he served as Director of Equity Research at Deutsche Bank, where he was a lead analyst covering the property and casualty insurance and insurance brokerage sectors. He brings more than 20 years of insurance and financial services experience, with a background spanning investor relations, equity research, financial analysis, and actuarial consulting, including roles at Citigroup, Aon, Ernst & Young, and AIG. He holds an MBA in finance and global business from New York University's Stern School of Business and a BBA in actuarial science from Temple University.
“We are pleased to welcome Phil to Octave,” David Trick, Executive Vice P...
|
|
|
|
|
|
|
08.09.26 - 12:33
|
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors (Business Wire)
|
|
|
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the appointment of Sean M. Salmon to its Board of Directors, effective September 8, 2026.
Mr. Salmon brings over three decades of global leadership experience in the medical device and pharmaceutical industries, culminating in more than 20 years at Medtronic plc (NYSE: MDT). He most recently served as Executive Vice President and President of its Cardiovascular Portfolio, a global business with fiscal 2025 revenue of approximately $12.5 billion for which Mr. Salmon was instrumental in developing the growth strategy. He previously held leadership roles across Medtronic's Diabetes, Coronary and Structural Heart, and Coronary and Renal Denervation businesses. Mr. Salmon currently serves as an independent director of Adagio Medical Holdings, Inc. (Nasdaq: ADGM).
“We are pleased to welcome Sean to the Teleflex Board,” said Andrew A. Krakauer, Chairman of the Teleflex Board of D...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
